APA (7th ed.) Citation

Tatsuhige, R., Yokoo, K., Hatakeyama, T., Nagao, T., Ota, S., Yamada, G., & Chiba, H. Interstitial Lung Disease due to Tepotinib after Durvalumab in a Patient with Lung Adenocarcinoma Harbouring MET Exon 14 Skipping Mutation: A Case Report. Karger Publishers.

Chicago Style (17th ed.) Citation

Tatsuhige, Ryota, Keiki Yokoo, Taku Hatakeyama, Takayuki Nagao, Satoshi Ota, Gen Yamada, and Hirofumi Chiba. Interstitial Lung Disease Due to Tepotinib After Durvalumab in a Patient with Lung Adenocarcinoma Harbouring MET Exon 14 Skipping Mutation: A Case Report. Karger Publishers.

MLA (9th ed.) Citation

Tatsuhige, Ryota, et al. Interstitial Lung Disease Due to Tepotinib After Durvalumab in a Patient with Lung Adenocarcinoma Harbouring MET Exon 14 Skipping Mutation: A Case Report. Karger Publishers.